Vetter Pharma-Fertigung GmbH
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Vetter Pharma-Fertigung GmbH
Final Revisions Should Ease Global Use Of EU GMP Annex I Sterile Drugs Guidance, Associations Say
Inter-associations working group suggests changes to the EU GMP Annex I revision to make it easier to understand by health authorities worldwide; the groups point out that the annex will be used globally and not just in Europe.
The Factory Floor: Carbogen Amcis, PCI Pharma And Vetter Expand In Europe
Carbogen Amcis, LGM Pharma, Vetter and PCI Pharma are focusing on expanding their businesses, while ChemWerth has filed its 500th drug master file for clevidipine with the FDA.
Lessons From COVID-19: How Pharma Supply Chains Must Evolve Before Next Disaster
Experts describe the agile, localized supply chains that will emerge, only perhaps to be forgotten just-in-time for the next crisis.
How Some Manufacturers Are Navigating COVID-19 Pharma Supply Chain Challenges
Gilead, Vetter, Lonza and academic experts share what they’re focusing on to keep producing drugs during the pandemic.
Company Information
- Industry
- Medical Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice